Intensity-modulated radiation therapy (IMRT) should be the preferred choice when treating patients with locally advanced non-small cell lung cancer (NSCLC), as it reduces radiation exposure to the ...

SAN FRANCISCO, September 29, 2025 — A new phase III clinical trial finds that intensity-modulated radiation therapy (IMRT) and proton beam therapy resulted in similar quality-of-life outcomes and low ...

St. Joseph Regional Medical Center has announced the addition of a second linear accelerator to its cancer treatment program.

For patients with advanced oropharyngeal cancer, proton therapy may beat photon radiotherapy in terms of overall survival and toxicity.

The Nature Index 2025 Research Leaders — previously known as Annual Tables — reveal the leading institutions and countries/territories in the natural and health sciences, according to their output in ...

Background: Radiotherapy device (OXRAY) using an O-ring-type linear accelerator system was developed in Japan. In this study, we aimed to compare dose distributions using biaxially rotational dynamic ...

According to preliminary data from a multi-institution Phase III trial led by researchers at The University of Texas MD Anderson Cancer Center, intensity modulated proton therapy (IMPT) achieved ...

Study represents the largest randomized Phase III trial comparing proton to traditional radiation with photons for ...